Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
作者信息
Stalder Grégoire, Suffiotti Madeleine, Segot Amandine, Noto Alessandra, Pantaleo Giuseppe, Spertini Olivier, Obeid Michel
机构信息
Service and Central Laboratory of Hematology, Lausanne University Hospital, rue du Bugnon 46, CH-1011 Lausanne, Switzerland; Service of Hematology and Laboratory of Hematology, Institut Central des Hôpitaux, Hôpital du Valais, Av. du Grand-Champsec 86, CH-1951 Sion, Switzerland; University of Lausanne, Lausanne.
Division of Immunology and Allergy, Lausanne University Hospital, rue du Bugnon 46, CH-1011 Lausanne.
出版信息
Haematologica. 2023 Jan 1;108(1):234-239. doi: 10.3324/haematol.2022.281221.
Abstract
摘要
Zotero 插件